Queen CBD 20:1 Feminised Seeds



Please select pack size below


We send seeds in discreet stealth packaging worldwide.


We're Social - Spread the Love

Queen CBD 20:1 Feminised Cannabis Seeds by Medical Marijuana Genetics

Queen CBD 20:1 Feminised is the most stable and high yielding variety ever produced Medical Marijuana Genetics. CBD levels are never below 15% and THC averages 0.7%. In short, Queen CBD is a non-psychoactive cannabis strain, leaving users calm and relaxed whilst soothing ailments. It is 60% indica and is a cross of Candida and Purpurea Ticinensis.

Queen CBD 20:1 Feminised, just like its mother Candida, suits all growing environments flourishing in almost any climate, producing purple buds and high levels of limonene. As a result, Queen CBD is suitable for both indoor and outdoor/greenhouse grows. She is a high yielder with indoors growers expecting around 500g/m2 of grow space. Likewise, outdoors she will yield approximately 800g/plant.

An excellent medicinal strain suitable for treating symptoms of anxiety, autism, Alzheimer’s, epilepsy, fibromyalgia, PTSD and stress. Medical Marijuana Genetics state Queen CBD is suitable for treating childhood epilepsy. Providing the same access without the associated cost of prescription cannabis-based medicine. However, please note, Coffee Shop Seeds would never recommend giving children any cannabis based product without professional medical advice!

Buy Medical Marijuana Genetics’ Queen CBD Feminised Cannabis Seeds here at internets best value seed shop – Coffee Shop Seeds.


Medical Marijuana Genetics

Medical Marijuana Genetics first learnt of the therapeutic properties of the cannabis plant in 2014. Whilst desperately treating the symptoms of one of the founders mother’s late stage pancreatic cancer. Not long after her first dose of cannabis oil, she was able to move around relatively pain free. This enabled her to tend to her beloved garden, in the weeks leading up to her death. Medical Marijuana Genetics teamed with award winning breeders from Spain, with the initial aim of creating a line of CBD dominant cannabis strains. Using genetics from a number of well established strains, Medical Marijuana Genetics successfully created Candida (CD-1). Aptly named after the founder’s mother and meaning ‘bright light’ in Latin. Medical Marijuana Genetics have had results ranging from 20.65% CBD with 0.7% THC to 10.65% CBD to 0.39% THC. These percentages represent the highest known consistent ratios in a CBD-rich seed strain ever created in Europe. Medical Marijuana Genetics created a further 12 elite strains using Candida as a parent. They have selected their favourite's of these to release alongside their flagship Candida strain. These have been selected to provide access (within lawful jurisdiction) to the widest range of therapeutics that the cannabis plant, and CBD in particular, has to offer. This includes treatments for symptoms such chronic pain, inflammation, seizures, convulsions, gastro-intestinal disorders, nausea, vomiting, skin conditions, bacterial infections, anxiety, depression, cancer cell growth and much more. All of the strains that are being launched are CBD dominant and have a CBD content of over 8%, but some strains veer towards a 1:1 ratio. In 2017 MMG strains won 5 Spannabis Champions Cups in Barcelona and Madrid. The awards include a 1st (BCN), 2nd and 3rd place (MAD)  in CBD categories for Orinoco OR1, Candida CD1 and Nightingale NN1 and a 2nd and 3rd in the Indica category for as yet unreleased genetics.
Medical marijuana Genetics Cannabis Seed breeders


Candida x Purpurea Ticinensis

CBD Content

Minimum 15%

THC Content

0.5 – 0.8%


Flowering Time

60 days

Flowering Type







Greenhouse, Grows Indoors, Grows outdoors

Medical Conditions

, , , , , ,

Medical Properties



, ,


You may also like…